Product Details
Product Name:
Propanidid |
CAS No.:
1421-14-3 |
Purity:
99.39% |
Supply Ability:
10g |
Release date:
2024/11/20 |
Product Introduction
Bioactivity
Name | Propanidid |
Description | Propanidid (Sombrevin) is a gamma-aminobutyric acid type A receptor (GABAA) agonist and a fast-acting intravenous anesthetic that lowers arterial blood pressure. |
In vivo | In adult cats immobilized by D-tubocurarine, Propanidid (3-5 mg/kg; injected into the femoral vein; single dosage) reliably induced a change of 47.6 ± 5.6 degrees in the preferred orientation of 60% of neurons in the primary visual cortex, while in the remaining cells, the orientation remained stable throughout all stages of anesthesia[3]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | BAY-1420, Sombrevin | Propanidid | FBA1420 | FBA-1420 |
Inhibitors Related | Valproic acid sodium salt | Penicillin G sodium salt |
Related Compound Libraries | Bioactive Compound Library | Pain-Related Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:132562-26-6
$293.00 / 1mg
-
CAS:103582-41-8
$87.00 / 1mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |